These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25380948)

  • 1. Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report.
    Dęborska-Materkowska D; Kozińska-Przybył O; Mikaszewska-Sokolewicz M; Durlik M
    Transplant Proc; 2014 Oct; 46(8):2908-11. PubMed ID: 25380948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
    Cho JH; Lee JH; Park GY; Lim JH; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
    Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.
    Tsagalis G; Psimenou E; Nakopoulou L; Laggouranis A
    Artif Organs; 2011 Apr; 35(4):420-5. PubMed ID: 20637013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Treatment of Focal Segmental Glomerulosclerosis Recurrence in a Second Kidney Transplant Patient: A Case Report.
    Argiolas D; Carta E; Mascia G; Michittu MB; Piredda GB
    Transplant Proc; 2019; 51(1):223-225. PubMed ID: 30580884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
    Lionaki S; Vlachopanos G; Georgalis A; Liapis G; Skalioti C; Zavos G; Boletis JN
    Ren Fail; 2015 Jun; 37(5):777-83. PubMed ID: 25715638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L; Guzzo I; Laurenzi C; Vivarelli M; Parodi A; Barbano G; Camilla R; Scozzola F; Amore A; Ginevri F; Murer L
    Transplantation; 2009 Aug; 88(3):417-20. PubMed ID: 19667947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Preemptive Kidney Transplantation With Rituximab Induction in a Patient With Focal Segmental Glomerulosclerosis and Massive Nephrotic Syndrome: A Case Report.
    Kolonko A; Piecha G; Więcek A
    Transplant Proc; 2016 Nov; 48(9):3092-3094. PubMed ID: 27932154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen.
    Stewart ZA; Shetty R; Nair R; Reed AI; Brophy PD
    Transplant Proc; 2011 Dec; 43(10):3994-6. PubMed ID: 22172885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence.
    Chikamoto H; Hattori M; Kuroda N; Kajiho Y; Matsumura H; Fujii H; Ishizuka K; Hisano M; Akioka Y; Nozu K; Kaito H; Shimizu M
    Pediatr Transplant; 2012 Nov; 16(7):E286-90. PubMed ID: 22129369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.
    Audard V; Kamar N; Sahali D; Cardeau-Desangles I; Homs S; Remy P; Aouizerate J; Matignon M; Rostaing L; Lang P; Grimbert P
    Transpl Int; 2012 May; 25(5):e62-6. PubMed ID: 22409658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J; Scheuermann EH; Porubsky S; Kachel HG; Geiger H; Hauser IA
    Transpl Int; 2007 Jun; 20(6):558-62. PubMed ID: 17433091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis.
    Kumar J; Shatat IF; Skversky AL; Woroniecki RP; Del Rio M; Perelstein EM; Johnson VL; Mahesh S
    Pediatr Nephrol; 2013 Feb; 28(2):333-8. PubMed ID: 23052653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of rituximab on a native kidney and a post-transplant kidney with recurrence of focal segmental glomerulosclerosis.
    Ino A; Kaori S; Takei T; Nitta K
    CEN Case Rep; 2020 Aug; 9(3):195-199. PubMed ID: 31997159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports.
    Kamar N; Faguer S; Esposito L; Guitard J; Nogier MB; Durand D; Rostaing L
    Clin Nephrol; 2007 Apr; 67(4):250-4. PubMed ID: 17474562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient.
    Kumar D; Gourishankar S; Mueller T; Cockfield S; Weinkauf J; Vethanayagam D; Humar A
    Transpl Infect Dis; 2009 Apr; 11(2):167-70. PubMed ID: 18803617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis.
    Fornoni A; Sageshima J; Wei C; Merscher-Gomez S; Aguillon-Prada R; Jauregui AN; Li J; Mattiazzi A; Ciancio G; Chen L; Zilleruelo G; Abitbol C; Chandar J; Seeherunvong W; Ricordi C; Ikehata M; Rastaldi MP; Reiser J; Burke GW
    Sci Transl Med; 2011 Jun; 3(85):85ra46. PubMed ID: 21632984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of recurrent focal segmental glomerulosclerosis (FSGS) involving massive proteinuria (>50 g/day) immediately after renal transplantation.
    Okamoto M; Koshino K; Sakai K; Nobori S; Matsuyama M; Ushigome H; Okajima H; Masuzawa N; Yoshimura N
    Clin Transplant; 2011 Jul; 25 Suppl 23():53-8. PubMed ID: 21623916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab for post-transplant recurrences of FSGS.
    Bayrakci US; Baskin E; Sakalli H; Karakayali H; Haberal M
    Pediatr Transplant; 2009 Mar; 13(2):240-3. PubMed ID: 18822107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
    Naciri Bennani H; Bonzi JY; Noble J; Terrec F; Motte L; Imerzoukene F; Bugnazet M; Giovannini D; Janbon B; Malvezzi P; Rostaing L; Jouve T
    Blood Purif; 2020; 49(3):322-333. PubMed ID: 31913143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.